Increasing prevalence of cancer cases is driving the market of next generation sequencing over the forecast period.
Published Date : 01/03/2018

Report : Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product (Platforms, Services, Consumables); Service (Genome Sequencing, Exome Sequencing, Re-sequencing & Targeted Sequencing, Other Sequencing Technologies); Application (Diagnostics, Drug Discovery, Precision Medicine, Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Other End Users)

According to The Insight Partners market research study titled 'Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Services, Applications, and End-Users, the global next generation sequencing market was valued at US$ 5,731.3 Mn in 2017 and is estimated to reach US$ 26,501.2 Mn by 2025. The report highlights the trends prevalent in the global next generation sequencing market and the factors driving the market along with those that act as deterrents to its growth.

The global next generation sequencing market is a matured market in the developing countries as well as developing economies worldwide. The necessity of genetic analysis is constantly increasing in recent days due to the reliable and accurate results being offered by the technique. The demand for next generation sequencing is experienced mostly from academic institutions followed by hospitals & clinics. Among the applications, the demand for next generation sequencing is significantly high in diagnostics, drug discovery, followed by precision medicine. Furthermore, advancements in sequencing technologies and declining cost of sequencing is expected to be a driving factor for the next generation market.

Modification and automation of this process continued to increase sequencing data and time reduction. Thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence based gene expression analysis a "digital? alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR. Advancement in genome sequencing has made the sequencing easy and accurate. These technological advancement are likely to grow the market in near future.

Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, NGS also aids in diagnostics and treatment of cancer. In recent years, the cases of cancer has been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. Due to preference of better technologies for detection of fatal disease, the demand for next generation sequencing is anticipated to witness constant growth in the upcoming years.

The market for next generation sequencing is well established in the region of North America, owing to the awareness regarding medical practices and technological developments in the process of next generation technology. Various market players have been focusing towards shifting their customer base in North America. For instance, Illumina, Inc. along with Telegraph, established a company called Verogen. The company would be entitled to provide Illumina's forensic products to the customers in the US.


The key players operating in the field of Next Generation Sequencing worldwide include PerkinElmer, Inc., Oxford Nanopore Technologies, Ltd., Beijing Genomics Institute, Macrogen, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Eurofins Scientific, Qiagen N.V., Thermo Fisher Scientific, and Illumina, Inc. among others

The report segments the global next generation sequencing market as follows:

Global Next Generation Sequencing Market – By Product

  • Consumables
    • Sample Preparation Consumables
      • DNA fragmentation, End Repair, A-Tailing, and Size Selection Kits & Reagents
      • Library Preparation & Target Enrichment Kits & Reagents
      • Quality Control Kits & Reagents
    • Other NGS Consumables
  • Services
    • Sequencing Services
      • RNA sequencing Services
      • Whole Genome Sequencing Services
      • Whole Exome Sequencing Services
      • Targeted Sequencing Services
      • Chip Sequencing Services
      • Other Sequencing Services
    • Data Management & Analysis Services
      • NGS Data Analysis
      • NGS Data Analysis Software & Workbenches
      • Other Data Management & Analysis Services
  • Platforms
    • HiSeq Series
    • MiSeq Series
    • SOLiD
    • Ion Torrent
    • Pacbio Rs II and Sequel Systems
    • Others


Global Next Generation Sequencing Market – By Technology

  • Genome Sequencing
  • Exome Sequencing
  • Resequencing & Targeted Sequencing
    • DNA-based Resequencing & Targeted Sequencing
    • RNA-based Resequencing & Targeted Sequencing
  • Others


Global Next Generation Sequencing Market – By Component

  • Diagnostics
  • Drug Discovery
  • Precision Medicine
  • Others


Global Next Generation Sequencing Market – By End User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Others

 

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

DOWNLOAD PDF BROCHURE